Elise Ballot
Inserm(FR)Université de Bourgogne(FR)Centre Georges François Leclerc(FR)Université Bourgogne Franche-Comté(FR)Centre de recherche Translationnelle en Médecine moléculaire(FR)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, PARP inhibition in cancer therapy, DNA Repair Mechanisms, Cancer Genomics and Diagnostics
Most-Cited Works
- → MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells(2022)205 cited
- → Follicular helper-T cells restore CD8+-dependent antitumor immunity and anti-PD-L1/PD-1 efficacy(2021)102 cited
- → First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial(2023)101 cited
- → Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses(2022)89 cited
- → Targeting PD-L1 and TIGIT could restore intratumoral CD8 T cell function in human colorectal cancer(2022)64 cited
- → Immunodynamics of explanted human tumors for immuno‐oncology(2020)37 cited